Ma2 Antibody, ELISA, Spinal Fluid
Use
Ma2 antibodies are IgG biomarkers found in patients with paraneoplastic encephalitis (limbic encephalitis or brainstem encephalitis) or cerebellar ataxia. Antibodies (Ab) to Ma antigens can be found directed at Ma2 alone, or both Ma1 and Ma2, but never Ma1 alone. The accompanying neurological disorders (encephalitis, dementia, brainstem encephalitis, cerebellar ataxia) are usually severe. The cancer associations are either testicular germinoma (Ma2 Ab positive only) or diverse (Ma1 and Ma2 Ab positive). Neurological improvement upon treatment of cancer or immunotherapy is more commonly encountered in those seropositive for Ma2 only than when compared to Ma1 and Ma2 together.
Special Instructions
Not provided.
Limitations
A negative Ma2 antibody test result does not exclude autoimmune neurological disease or cancer.
Methodology
Immunoassay (ELISA)
Biomarkers
PNMA2
Protein
LOINC Codes
- 101867-0 - Ma2 Ab CSF Ql IA
- 101867-0 - Ma2 Ab CSF Ql IA
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
2 mL
Minimum Volume
1 mL
Container
Sterile vial
Collection Instructions
Preferred: Vial number 1; Acceptable: Any vial
Storage Instructions
Refrigerated (preferred), Ambient for 72 hours, Frozen for 28 days
Causes for Rejection
Gross hemolysis, Gross lipemia, Gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 28 days |
| Frozen | 28 days |
